文献
J-GLOBAL ID:201802251344093005
整理番号:18A1601338
日本における市販後サーベイランスデータベースを用いたHMG-CoAレダクターゼ阻害剤による高尿酸血症の危険因子
Risk Factors for Hyperuricemia with HMG-CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan
著者 (6件):
HASHIGUCHI Masayuki
(Division for Evaluation and Analysis of Drug Information, Faculty of Pharmacy, Keio University)
,
HAKAMATA Jun
(Division for Evaluation and Analysis of Drug Information, Faculty of Pharmacy, Keio University)
,
SHIMIZU Mikiko
(Department of Hygienic Chemistry, Faculty of Pharmacy, Keio University)
,
MARUYAMA Junya
(Division for Evaluation and Analysis of Drug Information, Faculty of Pharmacy, Keio University)
,
SHIGA Tsuyoshi
(Department of Cardiology, Tokyo Women’s Medical University)
,
MOCHIZUKI Mayumi
(Division for Evaluation and Analysis of Drug Information, Faculty of Pharmacy, Keio University)
資料名:
臨床薬理
(Japanese Journal of Clinical Pharmacology and Therapeutics)
巻:
49
号:
4
ページ:
145-150(J-STAGE)
発行年:
2018年
JST資料番号:
F0384B
ISSN:
0388-1601
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
日本 (JPN)
言語:
英語 (EN)